Skip to main content

Sivelestat

  • Reference work entry
  • First Online:
Encyclopedia of Cancer
  • 109 Accesses

Definition

Sivelestat is a low molecular weight synthetic inhibitor of human neutrophil elastase (NE) (neutrophil elastase and cancer), which was produced by Ono Pharmaceutical Company Co., Ltd., in 1991 as ONO-5046, N-[2-{4-(2,2-dimethylpropionyloxy) phenylsulfonylamino}-benzoyl]aminoacetic acid (MW. 434.47). The structure is illustrated in Fig. 1. This is a potent, specific, and intravenously active NE inhibitor and it is widely used to treat patients with lung injury diagnosed as SIRS (systemic inflammatory response syndrome) in Japan at a dose of 0.2 mg/kg/h for 14 days.

Sivelestat, Fig. 1
figure 1931 figure 1931

Structure of sivelestat, ONO-5046, N-[2-{4-(2,2-dimethylpropionyloxy) phenylsulfonylamino}-benzoyl] aminoacetic acid (MW. 434.47)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 2,499.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 3,999.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • DiCamillo SJ, Carreras I, Panchenko MV et al (2002) Elastase-released epidermal growth factor recruits epidermal growth factor receptor and extracellular signal-regulated kinases to down-regulate tropoelastin mRNA in lung fibroblasts. J Biol Chem 277:18938–18946

    Article  CAS  PubMed  Google Scholar 

  • Kawabata K, Suzuki M, Sugitani M et al (1991) ONO-5046, a novel inhibitor of human neutrophil elastase. Biochem Biophys Res Commun 177:814–820

    Article  CAS  PubMed  Google Scholar 

  • Matsuzaki K, Hiramatsu Y, Homma S et al (2005) Sivelestat reduces inflammatory mediators and preserves neutrophil deformability during simulated extracorporeal circulation. Ann Thorac Surg 80:611–617

    Article  PubMed  Google Scholar 

  • Tamakuma S, Ogawa M, Aikawa N et al (2004) Relationship between neutrophil elastase and acute lung injury in humans. Pulm Pharmacol Ther 17:271–279

    Article  CAS  PubMed  Google Scholar 

  • Wada Y, Yoshida K, Hihara J et al (2006) Sivelestat, a specific neutrophil elastase inhibitor, suppresses the growth of gastric carcinoma cells by preventing the release of transforming growth factor-alpha. Cancer Sci 97:1037–1043

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kazuhiro Yoshida .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this entry

Cite this entry

Yoshida, K. (2015). Sivelestat. In: Schwab, M. (eds) Encyclopedia of Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46875-3_5332

Download citation

Publish with us

Policies and ethics